| Genetic Examination of SETD7 and SUV39H1/H2 Methyltransferases and the Risk of Diabetes Complications in Patients With Type 1 Diabetes. | |
| | |
MedLine Citation:
|
PMID: 21896933 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
OBJECTIVEHyperglycemia plays a pivotal role in the development and progression of vascular complications, which are the major sources of morbidity and mortality in diabetes. Furthermore, these vascular complications often persist and progress despite improved glucose control, possibly as a result of prior episodes of hyperglycemia. Epigenetic markers mediated by histone methyltransferases are associated with gene activating events that promote enhanced expression of key proinflammatory molecules implicated in vascular injury. In this study, we investigated genetic polymorphisms of the SETD7, SUV39H1, and SUV39H2 methyltransferases as predictors of risk for micro- and macrovascular complications in type 1 diabetes.RESEARCH DESIGN AND METHODSIn the Finnish Diabetic Nephropathy Study (FinnDiane) cohort, 37 tagSNPs were genotyped in 2,991 individuals with type 1 diabetes and diabetic retinopathy, diabetic nephropathy, and cardiovascular disease. Seven single nucleotide polymorphisms (SNPs) were genotyped in the replication cohorts from the Steno Diabetes Center and All Ireland/Warren 3/GoKinD U.K. study.RESULTSIn a meta-analysis, the minor T allele of the exonic SNP rs17353856 in the SUV39H2 was associated with diabetic retinopathy (genotypic odds ratio 0.75, P = 1.2 × 10(-4)). The same SNP showed a trend toward an association with diabetic nephropathy as well as cardiovascular disease in the FinnDiane cohort.CONCLUSIONSOur findings propose that a genetic variation in a gene coding for a histone methyltransferase is protective for a diabetic microvascular complication. The pathophysiological implications of this polymorphism or other genetic variation nearby for the vascular complications of type 1 diabetes remain to be investigated. |
| | |
Authors:
|
Anna Tiitu; Assam El-Osta; Carol Forsblom; Niina Sandholm; Maikki Parkkonen; Lise Tarnow; Hans-Henrik Parving; Amy J McKnight; Alexander P Maxwell; Mark E Cooper; Per-Henrik Groop; |
Related Documents
:
|
6792023 - Thyrotropin-releasing hormone increases plasma levels of glucagon, insulin, glucose and... 3041313 - Glucose metabolism alterations in friedreich's ataxia. 2884123 - Phentolamine reverses npy-induced inhibition of insulin secretion in isolated rat islets. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-9-6 |
Journal Detail:
|
Title: Diabetes Volume: - ISSN: 1939-327X ISO Abbreviation: - Publication Date: 2011 Sep |
Date Detail:
|
Created Date: 2011-9-7 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372763 Medline TA: Diabetes Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Expansion of Th17 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancrea...
Next Document: Impact of resistance training on blood pressure and other cardiovascular risk factors: a meta-analys...